Large Cap Archives - Page 331 of 437

1 minute read

AbbVie’s Preventive Treatment For Migraine Meets Primary Goal In Patients With Failed Medications

April 21, 7:24 AM

AbbVie Inc (NYSE: ABBV) announced data from its Phase 3 ELEVATE study, evaluating atogepant for the preventive treatment of episodic migraine in people who had previously failed two to four classes of oral preventive medications.

ABBV

2 minute read

Why Steel Dynamics Shares Are Soaring Today

By Lekha Gupta

April 20, 1:23 PM

Steel Dynamics Inc (NASDAQ: STLD) shares are gaining around 8% today, following its mixed bag of first-quarter 2023 results. The company remains confident that market conditions are in place for solid domestic steel consumption.

STLD

1 minute read

Blackstone Q1 Earnings Miss: Weak Real Estate Business Weigh On Distributable Earnings

By Lekha Gupta

April 20, 1:06 PM

Blackstone Inc (NYSE:BX) reported Q1 revenues of $2.49 billion, down 29% Y/Y and missing the consensus of $2.57 billion. Distributable…

1 minute read

BeiGene’s Tislelizumab/Chemo Combo Hits Primary Goal In Gastric Cancer Study

By Vandana Singh

April 20, 11:50 AM

BeiGene Ltd’s (NASDAQ:BGNE) global RATIONALE 305 Phase 3 trial met its primary endpoint of overall survival, with tislelizumab in combination with…

BGNE

2 minute read

Rio Tinto Touts Record Q1 Iron Ore Shipments, Expects ‘Significant’ Inflation Risk

By Vandana Singh

April 20, 11:43 AM

Rio Tinto plc (NYSE: RIO) continues to make "steady progress" with its "highest-ever first quarter shipments" achieved in the Western Australia iron ore business, according to CEO Jakob Stausholm.

RIO

2 minute read

Union Pacific Q1 Results Miss Estimates, But Revenue Grows And Derailment Rate Improves

By Akanksha Bakshi

April 20, 10:48 AM

Union Pacific Corp (NYSE: UNP) reported first-quarter FY23 operating revenue growth of 3.3% year-over-year to $6.06 billion, missing the consensus of $6.07 billion.

UNP

2 minute read

Discover Financials Q1 Triumph: Revenue Surges, 26% NII Growth, $2.7B Share Buyback, And 17% Dividend Hike

By Lekha Gupta

April 20, 10:10 AM

Discover Financial Services (NYSE: DFS) reported Q1 revenues (net of interest expense) of $3.75 billion, up 29% Y/Y,

DFS

1 minute read

FDA Approves Roche’s Polivy Combo Therapy For Untreated Patients With Diffuse Large B-Cell Lymphoma

By Vandana Singh

April 20, 9:53 AM

The FDA has approved Roche Group AG’s (OTC:RHHBY) Genentech’s Polivy (polatuzumab vedotin-piiq) in combination with Rituxan (rituximab), cyclophosphamide, doxorubicin and prednisone (R-CHP) for…

RHHBF